SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. Nattrass, L. Faulkner, M. Vocanson, D. J. Antoine, A. Kipar, G. Kenna, J.-F. Nicolas, B. K. Park, D. J. Naisbitt, Activation of Flucloxacillin-Specific CD8+ T-Cells With the Potential to Promote Hepatocyte Cytotoxicity in a Mouse Model, Toxicological Sciences, 2015, 146, 1, 146

    CrossRef

  2. 2
    J. Krauskopf, F. Caiment, S. M. Claessen, K. J. Johnson, R. L. Warner, S. J. Schomaker, D. A. Burt, J. Aubrecht, J. C. Kleinjans, Application of High-Throughput Sequencing to Circulating microRNAs Reveals Novel Biomarkers for Drug-Induced Liver Injury, Toxicological Sciences, 2015, 143, 2, 268

    CrossRef

  3. 3
    Benjamin L. Woolbright, Kenneth Dorko, Daniel J. Antoine, Joanna I. Clarke, Parviz Gholami, Feng Li, Sean C. Kumer, Timothy M. Schmitt, Jameson Forster, Fang Fan, Rosalind E. Jenkins, B. Kevin Park, Bruno Hagenbuch, Mojtaba Olyaee, Hartmut Jaeschke, Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis, Toxicology and Applied Pharmacology, 2015, 283, 3, 168

    CrossRef

  4. 4
    Michael E. Mullins, Allison J. McGovern, Can AST/ALT ratio indicate recovery after acute paracetamol poisoning? The authors reply, Clinical Toxicology, 2015, 53, 6, 581

    CrossRef

  5. 5
    Daniel J. Antoine, Venkata S. Sabbisetti, Ben Francis, Andrea L. Jorgensen, Darren G.N. Craig, Kenneth J. Simpson, Joseph V. Bonventre, B. Kevin Park, James W. Dear, Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver Injury, Hepatology, 2015, 62, 1
  6. 6
    B. L. F. Kaplan, J. Li, J. J. LaPres, S. B. Pruett, P. W. F. Karmaus, Contributions of Nonhematopoietic Cells and Mediators to Immune Responses: Implications For Immunotoxicology, Toxicological Sciences, 2015, 145, 2, 214

    CrossRef

  7. 7
    Hoi Y. Tong, Nicolás Medrano, Alberto M. Borobia, Ana M. Martínez, Julia Martín, José A. Ruiz, Santos García, Manuel Quintana, Antonio J. Carcas, Jesús Frías, Elena Ramírez, Hepatotoxicity induced by acute and chronic paracetamol overdose in adults. Where do we stand?, Regulatory Toxicology and Pharmacology, 2015, 72, 2, 370

    CrossRef

  8. 8
    Diana M Toivola, Peter Boor, Catharina Alam, Pavel Strnad, Keratins in health and disease, Current Opinion in Cell Biology, 2015, 32, 73

    CrossRef

  9. 9
    D Nicholas Bateman, James W. Dear, Limitations of AST/ALT ratio in paracetamol poisoning, Clinical Toxicology, 2015, 53, 6, 580

    CrossRef

  10. 10
    H. Yang, H. Wang, Z. Ju, A. A. Ragab, P. Lundback, W. Long, S. I. Valdes-Ferrer, M. He, J. P. Pribis, J. Li, B. Lu, D. Gero, C. Szabo, D. J. Antoine, H. E. Harris, D. T. Golenbock, J. Meng, J. Roth, S. S. Chavan, U. Andersson, T. R. Billiar, K. J. Tracey, Y. Al-Abed, MD-2 is required for disulfide HMGB1-dependent TLR4 signaling, Journal of Experimental Medicine, 2015, 212, 1, 5

    CrossRef

  11. 11
    R. Kia, L. Kelly, R. L. C. Sison-Young, F. Zhang, C. S. Pridgeon, J. A. Heslop, P. Metcalfe, N. R. Kitteringham, M. Baxter, S. Harrison, N. A. Hanley, Z. D. Burke, M. P. Storm, M. J. Welham, D. Tosh, B. Kuppers-Munther, J. Edsbagge, P. J. Starkey Lewis, F. Bonner, E. Harpur, J. Sidaway, J. Bowes, S. W. Fenwick, H. Malik, C. E. P. Goldring, B. K. Park, MicroRNA-122: A Novel Hepatocyte-Enriched in vitro Marker of Drug-Induced Cellular Toxicity, Toxicological Sciences, 2015, 144, 1, 173

    CrossRef

  12. 12
    D. Nicholas Bateman, Paracetamol poisoning: beyond the nomogram, British Journal of Clinical Pharmacology, 2015, 80, 1
  13. 13
    L. E. Walker, N. Mirza, V. L. M. Yip, A. G. Marson, M. Pirmohamed, Personalized medicine approaches in epilepsy, Journal of Internal Medicine, 2015, 277, 2
  14. 14
    Xi Yang, William F. Salminen, Qiang Shi, James Greenhaw, Pritmohinder S. Gill, Sudeepa Bhattacharyya, Richard D. Beger, Donna L. Mendrick, William B. Mattes, Laura P. James, Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children, Toxicology and Applied Pharmacology, 2015, 284, 2, 180

    CrossRef

  15. 15
    Heike Bantel, Thomas Thum, Klaus Schulze-Osthoff, Reply, Hepatology, 2015, 61, 4
  16. 16
    Peter Huebener, Jean-Philippe Pradere, Celine Hernandez, Geum-Youn Gwak, Jorge Matias Caviglia, Xueru Mu, John D. Loike, Rosalind E. Jenkins, Daniel J. Antoine, Robert F. Schwabe, The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis, Journal of Clinical Investigation, 2015, 125, 2, 539

    CrossRef

  17. 17
    April K Marrone, Frederick A Beland, Igor P Pogribny, The role for microRNAs in drug toxicity and in safety assessment, Expert Opinion on Drug Metabolism & Toxicology, 2015, 11, 4, 601

    CrossRef

  18. 18
    Richard D. Beger, Sudeepa Bhattacharyya, Xi Yang, Pritmohinder S. Gill, Laura K. Schnackenberg, Jinchun Sun, Laura P. James, Translational biomarkers of acetaminophen-induced acute liver injury, Archives of Toxicology, 2015,

    CrossRef

  19. 19
    Daniel J. Antoine, James W. Dear, Christopher E. Goldring, B. Kevin Park, Understanding the pathophysiological regulatory role of microRNAs in acute liver failure, Hepatology, 2015, 61, 4
  20. 20
    Anaïs Michaut, Caroline Moreau, Marie-Anne Robin, Bernard Fromenty, Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease, Liver International, 2014, 34, 7
  21. 21
    Mitchell R. McGill, Mengde Cao, Archie Svetlov, Matthew R. Sharpe, C. David Williams, Steven C. Curry, Anwar Farhood, Hartmut Jaeschke, Stanislav I. Svetlov, Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans, Biomarkers, 2014, 19, 3, 222

    CrossRef

  22. 22
    Rohit Singhal, Alison H Harrill, Francoise Menguy-Vacheron, Zaid Jayyosi, Hadj Benzerdjeb, Paul B Watkins, Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine, BMC Pharmacology and Toxicology, 2014, 15, 1, 42

    CrossRef

  23. 23
    Changchun Cai, Hai Huang, Sean Whelan, Li Liu, Benjamin Kautza, Jason Luciano, Guoliang Wang, Guoqiang Chen, Sladjana Stratimirovic, Allan Tsung, Timothy R. Billiar, Brian S. Zuckerbraun, Benzyl alcohol attenuates acetaminophen-induced acute liver injury in a Toll-like receptor-4-dependent pattern in mice, Hepatology, 2014, 60, 3
  24. 24
    Huailei Ma, Jing Ning, Xin Jin, Chunming Mao, Xiangli Bu, Miao Wang, Huan Liu, Kun Wang, Christopher Lausted, Leroy Hood, Jiankui Chen, Zhiyuan Hu, Betaine homocysteine methyltransferase (BHMT) as a specific and sensitive blood marker for acute liver injury, Biomarkers, 2014, 19, 7, 578

    CrossRef

  25. 25
    Min Yang, Daniel J. Antoine, James L. Weemhoff, Rosalind E. Jenkins, Anwar Farhood, B. Kevin Park, Hartmut Jaeschke, Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice, Liver Transplantation, 2014, 20, 11
  26. 26
    Akiko Eguchi, Alexander Wree, Ariel E. Feldstein, Biomarkers of liver cell death, Journal of Hepatology, 2014, 60, 5, 1063

    CrossRef

  27. You have free access to this content27
    James H. Lewis, Causality assessment: Which is best—expert opinion or RUCAM?, Clinical Liver Disease, 2014, 4, 1
  28. 28
    Tom Luedde, Neil Kaplowitz, Robert F. Schwabe, Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance, Gastroenterology, 2014, 147, 4, 765

    CrossRef

  29. 29
    Peter Lundbäck, Pernilla Stridh, Lena Klevenvall, Rosalind E. Jenkins, Marie Fischer, Erik Sundberg, Ulf Andersson, Daniel J. Antoine, Helena Erlandsson Harris, Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis, Antioxidants & Redox Signaling, 2014, 150206134954000

    CrossRef

  30. 30
    Mitchell R. McGill, Feng Li, Matthew R. Sharpe, C. David Williams, Steven C. Curry, Xiaochao Ma, Hartmut Jaeschke, Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans, Archives of Toxicology, 2014, 88, 2, 391

    CrossRef

  31. 31
    Xi Yang, Zuquan Weng, Donna L. Mendrick, Qiang Shi, Circulating extracellular vesicles as a potential source of new biomarkers of drug-induced liver injury, Toxicology Letters, 2014, 225, 3, 401

    CrossRef

  32. 32
    Anna-Karin M. Sjogren, Maria Liljevald, Björn Glinghammar, Johanna Sagemark, Xue-Qing Li, Anna Jonebring, Ian Cotgreave, Gabriella Brolén, Tommy B. Andersson, Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes, Archives of Toxicology, 2014, 88, 7, 1427

    CrossRef

  33. 33
    M. Ott, T. Cantz, A. Schneider, M.P. Manns, Diagnostik und Behandlung des akuten Leberversagens, Der Internist, 2014, 55, 11, 1288

    CrossRef

  34. 34
    Walid M Chalhoub, Kayla D Sliman, Meera Arumuganathan, James H Lewis, Drug-induced liver injury: what was new in 2013?, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 7, 959

    CrossRef

  35. 35
    Merrie Mosedale, Hong Wu, C. Lisa Kurtz, Stephen P. Schmidt, Karissa Adkins, Alison H. Harrill, Dysregulation of protein degradation pathways may mediate the liver injury and phospholipidosis associated with a cationic amphiphilic antibiotic drug, Toxicology and Applied Pharmacology, 2014, 280, 1, 21

    CrossRef

  36. 36
    James W. Dear, Daniel J. Antoine, Philip Starkey-Lewis, Christopher E. Goldring, B. Kevin Park, Early detection of paracetamol toxicity using circulating liver microRNA and markers of cell necrosis, British Journal of Clinical Pharmacology, 2014, 77, 5
  37. 37
    D. Nicholas Bateman, Robert Carroll, Janice Pettie, Takahiro Yamamoto, Muhammad E. M. O. Elamin, Lucy Peart, Margaret Dow, Judy Coyle, Kristina R. Cranfield, Christopher Hook, Euan A. Sandilands, Aravindan Veiraiah, David Webb, Alasdair Gray, Paul I. Dargan, David M. Wood, Simon H. L. Thomas, James W. Dear, Michael Eddleston, Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment, British Journal of Clinical Pharmacology, 2014, 78, 3
  38. 38
    B. L. Woolbright, M. R. McGill, V. S. Staggs, R. D. Winefield, P. Gholami, M. Olyaee, M. R. Sharpe, S. C. Curry, W. M. Lee, H. Jaeschke, Glycodeoxycholic Acid Levels as Prognostic Biomarker in Acetaminophen-Induced Acute Liver Failure Patients, Toxicological Sciences, 2014, 142, 2, 436

    CrossRef

  39. 39
    Rui Kang, Ruochan Chen, Qiuhong Zhang, Wen Hou, Sha Wu, Lizhi Cao, Jin Huang, Yan Yu, Xue-gong Fan, Zhengwen Yan, Xiaofang Sun, Haichao Wang, Qingde Wang, Allan Tsung, Timothy R. Billiar, Herbert J. Zeh, Michael T. Lotze, Daolin Tang, HMGB1 in health and disease, Molecular Aspects of Medicine, 2014, 40, 1

    CrossRef

  40. 40
    Petra Thulin, Gunnar Nordahl, Marcus Gry, Getnet Yimer, Eleni Aklillu, Eyasu Makonnen, Getachew Aderaye, Lars Lindquist, C. Mikael Mattsson, Björn Ekblom, Daniel J. Antoine, B. Kevin Park, Stig Linder, Alison H. Harrill, Paul B. Watkins, Björn Glinghammar, Ina Schuppe-Koistinen, Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts, Liver International, 2014, 34, 3
  41. 41
    Alison H. Harrill, John S. Eaddy, Kelly Rose, John M. Cullen, Lakshmi Ramanathan, Stephen Wanaski, Stephen Collins, Yu Ho, Paul B. Watkins, Edward L. LeCluyse, Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260, Toxicology and Applied Pharmacology, 2014, 277, 2, 131

    CrossRef

  42. 42
    Camilla Stephens, Raúl J. Andrade, M. Isabel Lucena, Mechanisms of drug-induced liver injury, Current Opinion in Allergy and Clinical Immunology, 2014, 14, 4, 286

    CrossRef

  43. 43
    Mitchell R McGill, Hartmut Jaeschke, Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 7, 1005

    CrossRef

  44. 44
    Perry H. Dubin, Hejun Yuan, Robert K. Devine, Linda S. Hynan, Mamta K. Jain, William M. Lee, Micro-RNA-122 levels in acute liver failure and chronic hepatitis C, Journal of Medical Virology, 2014, 86, 9
  45. 45
    Robert James Hornby, Philip Starkey Lewis, James Dear, Chris Goldring, B Kevin Park, MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans, Expert Review of Clinical Pharmacology, 2014, 7, 3, 349

    CrossRef

  46. 46
    Katharina John, Johannes Hadem, Till Krech, Kristin Wahl, Michael P. Manns, Steven Dooley, Sandor Batkai, Thomas Thum, Klaus Schulze-Osthoff, Heike Bantel, MicroRNAs play a role in spontaneous recovery from acute liver failure, Hepatology, 2014, 60, 4
  47. 47
    Ben Lu, Ce Wang, Mao Wang, Wei Li, Fangping Chen, Kevin J Tracey, Haichao Wang, Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review, Expert Review of Clinical Immunology, 2014, 10, 6, 713

    CrossRef

  48. 48
    Robert J. Fontana, Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives, Gastroenterology, 2014, 146, 4, 914

    CrossRef

  49. 49
    Munir Pirmohamed, Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions, Annual Review of Genomics and Human Genetics, 2014, 15, 1, 349

    CrossRef

  50. 50
    Anna Alisi, Valerio Nobili, Sara Ceccarelli, Nadia Panera, Cristiano De Stefanis, Rita De Vito, Roberta Vitali, Giorgio Bedogni, Clara Balsano, Salvatore Cucchiara, Laura Stronati, Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease, Expert Review of Molecular Diagnostics, 2014, 14, 6, 763

    CrossRef

  51. 51
    Minjun Chen, Jürgen Borlak, Weida Tong, Predicting idiosyncratic drug-induced liver injury – some recent advances, Expert Review of Gastroenterology & Hepatology, 2014, 8, 7, 721

    CrossRef

  52. 52
    D Nicholas Bateman, James W Dear, H K Ruben Thanacoody, Simon H L Thomas, Michael Eddleston, Euan A Sandilands, Judy Coyle, Jamie G Cooper, Aryelly Rodriguez, Isabella Butcher, Steff C Lewis, A D Bastiaan Vliegenthart, Aravindan Veiraiah, David J Webb, Alasdair Gray, Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial, The Lancet, 2014, 383, 9918, 697

    CrossRef

  53. 53
    Adriaan D.B. Vliegenthart, Philip Starkey Lewis, Carl S. Tucker, Jorge Del Pozo, Sebastein Rider, Daniel J. Antoine, Valérie Dubost, Magdalena Westphal, Pierre Moulin, Matthew A. Bailey, Jonathan G. Moggs, Chris E. Goldring, B. Kevin Park, James W. Dear, Retro-Orbital Blood Acquisition Facilitates Circulating microRNA Measurement in Zebrafish with Paracetamol Hepatotoxicity, Zebrafish, 2014, 11, 3, 219

    CrossRef

  54. 54
    Zhihua Qiu, Yimin Dai, Roadmap of miR-122-related clinical application from bench to bedside, Expert Opinion on Investigational Drugs, 2014, 23, 3, 347

    CrossRef

  55. 55
    Daniel J. Antoine, Alison H. Harrill, Paul B. Watkins, B. Kevin Park, Safety biomarkers for drug-induced liver injury – current status and future perspectives, Toxicol. Res., 2014, 3, 2, 75

    CrossRef

  56. 56
    Mitchell R. McGill, Vincent S. Staggs, Matthew R. Sharpe, William M. Lee, Hartmut Jaeschke, Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome, Hepatology, 2014, 60, 4
  57. 57
    James W Dear, Daniel J Antoine, Stratification of paracetamol overdose patients using new toxicity biomarkers: current candidates and future challenges, Expert Review of Clinical Pharmacology, 2014, 7, 2, 181

    CrossRef

  58. 58
    Haichao Wang, Mary F Ward, Andrew E Sama, Targeting HMGB1 in the treatment of sepsis, Expert Opinion on Therapeutic Targets, 2014, 18, 3, 257

    CrossRef

  59. 59
    J-X Li, J-M Feng, Y Wang, X-H Li, X-X Chen, Y Su, Y-Y Shen, Y Chen, B Xiong, C-H Yang, J Ding, Z-H Miao, The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury, Cell Death and Disease, 2014, 5, 6, e1278

    CrossRef

  60. 60
    David Nicholas Bateman, James W Dear, H K Ruben Thanacoody, Simon H L Thomas, Michael Eddleston, Treatment of paracetamol overdose – Authors'reply, The Lancet, 2014, 383, 9926, 1383

    CrossRef

  61. 61
    Kevin Park, Daniel J Antoine, Munir Pirmohamed, Treatment of paracetamol overdose: room for improvement?, The Lancet, 2014, 383, 9918, 672

    CrossRef

  62. 62
    Christine Bernsmeier, Charalambos G. Antoniades, Julia Wendon, What’s new in acute liver failure?, Intensive Care Medicine, 2014, 40, 10, 1545

    CrossRef

  63. 63
    Jiri Aubrecht, Shelli J Schomaker, David E Amacher, Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury, Genome Medicine, 2013, 5, 9, 85

    CrossRef

  64. 64
    Benjamin L. Woolbright, Daniel J. Antoine, Rosalind E. Jenkins, Mary Lynn Bajt, B. Kevin Park, Hartmut Jaeschke, Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice, Toxicology and Applied Pharmacology, 2013, 273, 3, 524

    CrossRef

  65. 65
    Laura P James, Prit Gill, Pippa Simpson, Predicting risk in patients with acetaminophen overdose, Expert Review of Gastroenterology & Hepatology, 2013, 7, 6, 509

    CrossRef

  66. 66
    Munir Pirmohamed, Mechanisms of Adverse Drug Reactions,
  67. 67
    Daniel J. Antoine, Mechanistic Safety Biomarkers for Drug-Induced Liver Injury,